DIA Biosimilars 2013

Articles Published in 2009

Coast IRB to Close in Wake of GAO Investigation

Monday, April 27, 2009 09:31 AM

Coast IRB, the institutional review board (IRB) that was the target of an undercover investigation by the Government Accountability Office (GAO), is closing its doors, according to reports published last week.

More... »

Cenduit: Now with Patient Reminders

Global Acquisitions Heat Up

Monday, April 27, 2009 08:00 AM

Three companies—Phase Forward, Chiltern International and ChemDiv—are the latest clinical trial companies to complete global acquisitions.

More... »

CRF Health – eCOA Forum

Ecron Acunova Founder Steps Down

Friday, April 24, 2009 08:29 AM

Ecron Acunova, a CRO based out of Germany, India and the United States, appointed Antal Hajos managing director and CEO Europe, replacing ECRON founder and CEO Klaus Wiedey, who will serve as an advisor to the company. In his new role, Hajos will oversee all business, strategic and operational aspects of the European operations. Prior to joining Ecron Acunova last year, Hajos was director of global clinical operations with Altana Pharma and later CEO of Altana/Nycomed’s research and development center and Indian affiliate in Mumbai, India.

More... »

Phase Forward Acquires Waban Software

Thursday, April 23, 2009 07:12 AM

Phase Forward, an eClinical company, acquired Waban Software, a Cambridge, Mass.-based clinical data analysis and reporting company with operations in Mumbai, India, for $14 million in cash.

More... »

PPD Earnings Down in Q1, Opens Office in Japan

Wednesday, April 22, 2009 08:00 AM

Wilmington, N.C-based contract research organization (CRO) PPD reported first quarter 2009 earnings late yesterday along with the opening of its first office in Japan and the completion of the acquisition of AbCRO, a Bulgarian CRO.

More... »

Chiltern Acquires Brazil CRO Vigiun

Tuesday, April 21, 2009 07:58 AM

UK-based contract research organization (CRO) Chiltern International continued its global expansion efforts with the acquisition of Vigiun, a CRO in São Paulo, Brazil, for an undisclosed amount.

More... »

Radiant Goes Global, Expands CRO Services into India

Monday, April 20, 2009 08:00 AM

Radiant Research’s recent partnership with India-based Spectrum Clinical Research will, for the first time, expand Radiant’s contract research organization (CRO) division beyond North America.

More... »

CenterWatch Announces May Release of “State of the Clinical Trials Industry”

Friday, April 17, 2009 08:00 AM

CenterWatch, a global source for clinical trials information, announced today the planned release of its fifth edition of the annual sourcebook, State of the Clinical Trials Industry, due out in late May.

More... »

GVK Biosciences Partners with Excel PharmaStudies in China

Thursday, April 16, 2009 08:04 AM

India-based contract research organization (CRO) GVK Biosciences formed a strategic alliance with Excel PharmaStudies, a CRO in China, to offer clinical trial services across India and China.

More... »

Coast IRB Halts New Study Submissions

Wednesday, April 15, 2009 07:53 AM

Facing FDA concerns about its ability to protect human subjects participating in clinical trials, Coast Institutional Review Board has voluntarily suspended the approval of new studies as well as the recruitment of new patients for ongoing studies.

More... »

`
CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs